Perspectives of carers on medication management in dementia:lessons from collaboratively developing a research proposal

Article English OPEN
Poland, Fiona ; Mapes, Sarah ; Pinnock, Hilary ; Katona, Cornelius ; Sorensen, Susanne ; Fox, Chris ; Maidment, Ian D (2014)
  • Publisher: Springer Nature
  • Journal: volume 7, pages 463-463 (eissn: 1756-0500)
  • Related identifiers: doi: 10.1186/1756-0500-7-463, pmc: PMC4112829
  • Subject: Medicines management | Biochemistry, Genetics and Molecular Biology(all) | Dementia | Medicine(all) | Family carers | Project Note | Service user engagement
    mesheuropmc: humanities | human activities | health care economics and organizations | social sciences | health care facilities, manpower, and services

Background: The need for carers to manage medication-related problems for people with dementia living in the community raises dilemmas, which can be identified by carers and people with dementia as key issues for developing carer-relevant research projects.A research planning Public Patient Involvement (PPI) workshop using adapted focus group methodology was held at the Alzheimer's Society's national office, involving carers of people with dementia who were current members of the Alzheimer's Society Research Network (ASRN) in dialogue with health professionals aimed to identify key issues in relation to medication management in dementia from the carer viewpoint. The group was facilitated by a specialist mental health pharmacist, using a topic guide developed systematically with carers, health professionals and researchers. Audio-recordings and field notes were made at the time and were transcribed and analysed thematically. The participants included nine carers in addition to academics, clinicians, and staff from DeNDRoN (Dementias and Neurodegenerative Diseases Research Network) and the Alzheimer's Society. Findings. Significant themes, for carers, which emerged from the workshop were related to: (1) medication usage and administration practicalities, (2) communication barriers and facilitators, (3) bearing and sharing responsibility and (4) weighing up medication risks and benefits. These can form the basis for more in-depth qualitative research involving a broader, more diverse sample. Discussion. The supported discussion enabled carer voices and perspectives to be expressed and to be linked to the process of identifying problems in medications management as directly experienced by carers. This was used to inform an agenda for research proposals which would be meaningful for carers and people with dementia. © 2014 Poland et al.; licensee BioMed Central Ltd.
  • References (20)
    20 references, page 1 of 2

    1. Alzheimers Disease International: World Alzheimer Report 2009. Available on: (Accessed 1 March 2013).

    2. Department of Health: Living well with dementia: a national dementia strategy. London: The Stationary Office; 2009. Available on uk/government/publications/living-well-with-dementia-a-national-dementiastrategy (accessed 6 January 2014).

    3. Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzagt F, Hui S, Hendrie HC: Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc 2006, 54:104-109.

    4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Kevin Park B, Breckenridge AM: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004, 329:15-19.

    5. Gomez-Pavon J, Gonzalez Garcia P, Frances Roman I, Gómez-Pavón J, González García P, Francés Román I, Vidán Astiz M, Gutiérrez Rodríguez J, Jiménez Díaz G, Montero Fernández NP, Alvarez Fernández B, Jiménez Páez JM: Recommendations for the prevention of adverse drug reactions in older adults with dementia. Revista espanola de geriatria y gerontologia 2010, 45:89-96.

    6. Maidment ID, Haw C, Stubbs J, Fox C, Katona C, Franklin BD: Medication errors in older people with mental health problems: a review. Int J Geriatr Psychiatry 2008, 23:564-573.

    7. Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G, Gray RJ: Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr Bull 2006, 32:786-794.

    8. National Institute of Health: Getting involved at NIH. Maryland: National of Institute of Health; 2005. Available on: public_participation.asp (accessed 22 December 2013).

    9. Department of Health: Research - what's in it for consumers? Report of the Standing Advisory Committee on Consumer Involvement in the NHS R&D Programme. London: The Stationary Office; 1998.

    10. Coulter A, McGee H: The European Patient of the Future. Maidenhead: Open University Press; 2003.

  • Metrics
    No metrics available
Share - Bookmark